Neuroblastomas have also been reported to harbor epigenetic deregulation involving H3K27 (29) that led to epigenetic silencing of tumor suppressor genes, and MYCN-amplified neuroblastomas were further found to effectively respond to H3K27 demethylation inhibition (30) using GSK-J4. This evidence concerns the gene MYCN and neuroblastoma.